Abstract
Effect size analysis of cipaglucosidase alfa plus miglustat versus alglucosidase alfa in ERT-experienced adults with late-onset Pompe disease in PROPEL
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have